[Chronic myeloid leukemia:specific characteristics and targeted therapy]

Lijec Vjesn. 2007 May:129 Suppl 3:5-9.
[Article in Croatian]
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Molecular Diagnostic Techniques
  • Piperazines / therapeutic use
  • Pyrimidines / therapeutic use

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate